TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CERS

Cerus Corporation

Healthcare · Medical Devices

2.70$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Cerus Corporation (CERS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 222 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CERS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
82 139 103 98 163 166 221 237 218 198 201 222
75 130 94 90 147 128 183 187 170 144 152 174
23 71 23 14 29 35 37 49 36 12 20 20
51 108 72 61 118 86 134 129 102 66 80 83
8.6 5.8 6.9 12 8.8 17 21 25 34 36 30 30
15 11 13 14 14 19 23 27 29 40 38 56
3.8 3.5 3.0 2.1 8.1 15 14 25 11
1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3
1.1 0.9 0.7 0.5 0.3 0.1
40 45 46 59 79 108 118 152 150 144 144 157
29 22 27 23 53 50 60 79 117 68 64 101
9.9 3.0 6.9 12 7.9 6.6 10 17 58 22 22 46
18 5.2 8.6 23 19 22 24 36 33 24 22 28
9.9 17 12 30 22 39 40 55 14 60 65 41
42 95 58 39 85 57 104 85 68 53 56 64
-542 -598 -661 -721 -779 -850 -910 -964 -1,007 -1,045 -1,066 -1,081
77 97 102 108 132 140 164 171 177 180 185 191

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?